The editor's roundtable: Statin therapy in acute coronary syndrome

被引：3

作者：

Friedewald, Vincent E. ^{[1
]}

McPherson, Ruth

Roberts, Robert

Roberts, William C.

Waters, David D.

机构：

[1] Univ Texas, Hlth Sci Ctr, Houston, TX USA

[2] Univ Ottawa, Inst Heart, Lipid Res Lab, Lipid Clin, Ottawa, ON K1N 6N5, Canada

[3] Baylor Heart & Vasc Inst, Dallas, TX USA

[4] Baylor Hlth Care Syst, Ctr Continuing Med Educ, Dallas, TX USA

[5] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2007年 / 99卷 / 02期

关键词：

D O I：

10.1016/j.amjcard.2006.10.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：213 / 221

页数：9

共 12 条

[1] Beneficial effects of Pravastatin (±colestyramine/niacin) initiated immediately after a coronary event (the randomized lipid-coronary artery disease [L-CAD] study) [J].

Arntz, HR ;

Agrawal, R ;

Wunderlich, W ;

Schnitzer, L ;

Stern, R ;

Fischer, F ;

Schultheiss, HP .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (12) :1293-1298

[2] Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[3] Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial [J].

de Lemos, JA ;

Blazing, MA ;

Wiviott, SD ;

Lewis, EF ;

Fox, KAA ;

White, HD ;

Rouleau, JL ;

Pedersen, TR ;

Gardner, LH ;

Mukherjee, R ;

Ramsey, KE ;

Palmisano, J ;

Bilheimer, DW ;

Pfeffer, MA ;

Califf, RM ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11) :1307-1316

[4] Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes -: The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial [J].

Dupuis, J ;

Tardif, JC ;

Cernacek, P ;

Théroux, P .

CIRCULATION, 1999, 99 (25) :3227-3233

[5] The effect of statin therapy on ventricular late potentials in acute myocardial infarction [J].

Kayikcioglu, M ;

Can, L ;

Evrengul, H ;

Payzin, S ;

Kultursay, H .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 90 (01) :63-72

[6] High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study [J].

Kinlay, S ;

Schwartz, GG ;

Olsson, AG ;

Rifai, N ;

Leslie, SJ ;

Sasiela, WJ ;

Szarek, M ;

Libby, P ;

Ganz, P .

CIRCULATION, 2003, 108 (13) :1560-1566

[7]

PEDERSEN TR, 1994, LANCET, V344, P1383

[8] Benefits of early lipid-lowering intervention in high-risk patients: The lipid intervention strategies for coronary patients study [J].

Pedersen, TR ;

Jahnsen, KE ;

Vatn, S ;

Semb, AG ;

Kontny, F ;

Zalmai, A ;

Nerdrum, T .

CLINICAL THERAPEUTICS, 2000, 22 (08) :949-960

[9] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

[10] Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial [J].

Schwartz, GG ;

Olsson, AG ;

Ezekowitz, MD ;

Ganz, P ;

Oliver, MF ;

Waters, D ;

Zeiher, A ;

Chaitman, BR ;

Leslie, S ;

Stern, T .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (13) :1711-1718

← 1 2 →